Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

Yoshida, R. et al.

Clinicopathological study of chromogranin A, B and BRCA1 expression in node-negative breast carcinoma.

Chromogranins are representative proteins contained in endocrine cells of various organs including some ductal cells of the breast. Homology between the BRCA1 protein (1214-1223) and the chromogranins has been detected and suggests that chromogranin may play the role of tumor suppressor like BRCA1. To evaluate whether chromogranins function as tumor suppressors in invasive breast carcinoma, we examined the clinicopathological significance and immunohistochemical expression of chromogranin and BRCA1 in 80 patients with lymph node-negative primary invasive ductal carcinomas. Chromogranin A (CgA) and chromogranin B (CgB) were positive in 21 (26%) and 30 cases (38%) respectively. Expression of CgA was correlated with PR, and lower histological grade (p<0.05 respectively). However, the expression of CgB was not correlated with any immunohistological factor. Expression of both CgA and CgB was not correlated with age, tumor size, and treatment modality. With multivariate analysis, expression of BRCA1 significantly influenced the expression of CgA (p=0.01), while no factor significantly influenced to the expression of CgB. The survival curve of the patients with CgA-negative tumor indicated a tendency to a poorer prognosis than that seen with CgA-positive tumor. The patients with CgB-negative tumors demonstrated a poorer prognosis than seen with patients with CgB-positive tumors (p<0.05). CgA and CgB may mediate tumor progression through some unknown function besides the BRCA1-related function.[1]

References

Clinicopathological study of chromogranin A, B and BRCA1 expression in node-negative breast carcinoma. Yoshida, R., Ohuchi, N., Kimura, N. Oncol. Rep. (2002) [Pubmed]

Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use apsburg

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.